Since 2003, scientist, researcher, entrepreneur, experienced business leader and executive Dr. Scott Rocklage has worked with 5AM Ventures. Initially, his role with the early state venture capital company was as a venture partner. A year after he joined the life-science focused company, he became managing partner. Learn more about Scott Rocklage: https://scottrocklage.wordpress.com/ and http://www.thestylemaponline.com/the-amazing-career-of-scott-rocklage-of-5am-ventures/
Dr. Rocklage has been working with scientists and physicians turned entrepreneurs to transform their ideas into medicines and medical treatments for more than three decades. He has also been an executive with or on the board of more than a dozen well-known biotech companies.
A graduate of the University of California, Berkley and the Massachusetts Institute of Technology with a bachelor’s degree and PhD in chemistry respectively, Dr. Scott Rocklage has long been on the cutting-edge of biomedical research. He helped get U.S. New Drug Applications approved by the Food and Drug Administration for Teslascan, Omniscan and Cubicin. Dr. Rocklage was also instrumental in getting clinical trials for a number of other drug candidates in the U.S.. He has also had his work appear in countless peer-reviewed scientific journals and holds almost three dozen U.S. patents.
Well organized and highly skilled at time management, prioritization and measured risk-taking, Dr. Scott Rocklage has been an invaluable help to early stages companies and medical professionals that choose to work on developing their innovative new medicine and treatments by becoming entrepreneurs rather than working with Fortune 500 companies.
He recommends budding entrepreneurs focus on their strengths and remain true to what they do well. At 5AM Ventures, Dr. Rocklage works on emerging life science areas and regularly meets with the portfolio management team and the board of directors. Read more: Scott Rocklage | Ideamesch and Scott Rocklage | Bloomberg
Explosive new medical breakthroughs that provide unique ways for physicians, oncologists and medical researchers to target the specific mutations and genotypes that cause cancer and has lead to new treatments for cancer and other disease are very exciting developments to Dr. Rocklage.
He is optimistic that in the not too distant future these breakthroughs will lead to effective new cutting-edge treatments that will both extend and save the lives of people suffering with cancer and many other diseases.
He sees his work at 5AM Ventures as helping to facilitate and hasten these exciting, badly needed improvements in medical care.
Dr. Scott Rocklage works in Menlo Park, California based 5AM Ventures’ offices in Boston, Massachusetts. He continues to work hard daily to help driven, visionary life science entrepreneurs to succeed.